235 related articles for article (PubMed ID: 34714302)
1. Immunogenic cell death inducers for enhanced cancer immunotherapy.
Li Y; Liu X; Zhang X; Pan W; Li N; Tang B
Chem Commun (Camb); 2021 Nov; 57(91):12087-12097. PubMed ID: 34714302
[TBL] [Abstract][Full Text] [Related]
2. Combination Cancer Immunotherapy of Nanoparticle-Based Immunogenic Cell Death Inducers and Immune Checkpoint Inhibitors.
Qi J; Jin F; Xu X; Du Y
Int J Nanomedicine; 2021; 16():1435-1456. PubMed ID: 33654395
[TBL] [Abstract][Full Text] [Related]
3. Recent progress in stimuli-responsive nanosystems for inducing immunogenic cell death.
Banstola A; Poudel K; Kim JO; Jeong JH; Yook S
J Control Release; 2021 Sep; 337():505-520. PubMed ID: 34314800
[TBL] [Abstract][Full Text] [Related]
4. Rediscovery of nanoparticle-based therapeutics: boosting immunogenic cell death for potential application in cancer immunotherapy.
Yang S; Sun IC; Hwang HS; Shim MK; Yoon HY; Kim K
J Mater Chem B; 2021 May; 9(19):3983-4001. PubMed ID: 33909000
[TBL] [Abstract][Full Text] [Related]
5. Natural Compounds of Marine Origin as Inducers of Immunogenic Cell Death (ICD): Potential Role for Cancer Interception and Therapy.
Sansone C; Bruno A; Piscitelli C; Baci D; Fontana A; Brunet C; Noonan DM; Albini A
Cells; 2021 Jan; 10(2):. PubMed ID: 33504012
[TBL] [Abstract][Full Text] [Related]
6. Immunogenic cell death-based cancer vaccines: promising prospect in cancer therapy.
Wang J; Ma J; Xie F; Miao F; Lv L; Huang Y; Zhang X; Yu J; Tai Z; Zhu Q; Bao L
Front Immunol; 2024; 15():1389173. PubMed ID: 38745666
[TBL] [Abstract][Full Text] [Related]
7. Sensitize Tumor Immunotherapy: Immunogenic Cell Death Inducing Nanosystems.
Peng J; Li S; Ti H
Int J Nanomedicine; 2024; 19():5895-5930. PubMed ID: 38895146
[TBL] [Abstract][Full Text] [Related]
8. Natural compound inducers of immunogenic cell death.
Diederich M
Arch Pharm Res; 2019 Jul; 42(7):629-645. PubMed ID: 30955159
[TBL] [Abstract][Full Text] [Related]
9. Nanotechnology-enabled immunogenic cell death for improved cancer immunotherapy.
Li W; Jiang Y; Lu J
Int J Pharm; 2023 Mar; 634():122655. PubMed ID: 36720448
[TBL] [Abstract][Full Text] [Related]
10. Immunogenic cell death in cancer therapy: Present and emerging inducers.
Zhou J; Wang G; Chen Y; Wang H; Hua Y; Cai Z
J Cell Mol Med; 2019 Aug; 23(8):4854-4865. PubMed ID: 31210425
[TBL] [Abstract][Full Text] [Related]
11. Stimuli-responsive nanodelivery systems for amplifying immunogenic cell death in cancer immunotherapy.
Xu W; Liu W; Yang J; Lu J; Zhang H; Ye D
Immunol Rev; 2024 Jan; 321(1):181-198. PubMed ID: 37403660
[TBL] [Abstract][Full Text] [Related]
12. Reinforcing the immunogenic cell death to enhance cancer immunotherapy efficacy.
Yu S; Xiao H; Ma L; Zhang J; Zhang J
Biochim Biophys Acta Rev Cancer; 2023 Sep; 1878(5):188946. PubMed ID: 37385565
[TBL] [Abstract][Full Text] [Related]
13. Targeting immunogenic cell stress and death for cancer therapy.
Galluzzi L; Guilbaud E; Schmidt D; Kroemer G; Marincola FM
Nat Rev Drug Discov; 2024 Jun; 23(6):445-460. PubMed ID: 38622310
[TBL] [Abstract][Full Text] [Related]
14. Multifunctional Nano-Biomaterials for Cancer Therapy via Inducing Enhanced Immunogenic Cell Death.
Chen Q; Li C; Wang Q
Small Methods; 2023 May; 7(5):e2201457. PubMed ID: 36703555
[TBL] [Abstract][Full Text] [Related]
15. Biomimetic Active Materials Guided Immunogenic Cell Death for Enhanced Cancer Immunotherapy.
Huang G; Liu L; Pan H; Cai L
Small Methods; 2023 May; 7(5):e2201412. PubMed ID: 36572642
[TBL] [Abstract][Full Text] [Related]
16. Immunogenic cell death in cancer immunotherapy.
Choi M; Shin J; Lee CE; Chung JY; Kim M; Yan X; Yang WH; Cha JH
BMB Rep; 2023 May; 56(5):275-286. PubMed ID: 37081756
[TBL] [Abstract][Full Text] [Related]
17. Metal-based anticancer agents as immunogenic cell death inducers: the past, present, and future.
Sen S; Won M; Levine MS; Noh Y; Sedgwick AC; Kim JS; Sessler JL; Arambula JF
Chem Soc Rev; 2022 Feb; 51(4):1212-1233. PubMed ID: 35099487
[TBL] [Abstract][Full Text] [Related]
18. Bioactive Peptide Nanodrugs Based on Supramolecular Assembly for Boosting Immunogenic Cell Death-Induced Cancer Immunotherapy.
Liu Y; Chang R; Xing R; Yan X
Small Methods; 2023 May; 7(5):e2201708. PubMed ID: 36720041
[TBL] [Abstract][Full Text] [Related]
19. Immunogenic Cell Death and Role of Nanomaterials Serving as Therapeutic Vaccine for Personalized Cancer Immunotherapy.
Catanzaro E; Feron O; Skirtach AG; Krysko DV
Front Immunol; 2022; 13():925290. PubMed ID: 35844506
[TBL] [Abstract][Full Text] [Related]
20. Nanomedicine to aid immunogenic cell death (ICD)-based anticancer therapy.
Demuynck R; Engelen Y; Skirtach AG; De Smedt SC; Lentacker I; Krysko DV
Trends Cancer; 2024 Jun; 10(6):486-489. PubMed ID: 38553361
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
